112 related articles for article (PubMed ID: 18450729)
1. Early-onset haemochromatosis caused by a novel combination of TFR2 mutations(p.R396X/c.1538-2 A>G) in a woman of Italian descent.
Gérolami V; Le Gac G; Mercier L; Nezri M; Bergé-Lefranc JL; Férec C
Haematologica; 2008 May; 93(5):e45-6. PubMed ID: 18450729
[No Abstract] [Full Text] [Related]
2. Homozygous p.M172K mutation of the TFR2 gene in an Italian family with type 3 hereditary hemochromatosis and early onset iron overload.
Majore S; Milano F; Binni F; Stuppia L; Cerrone A; Tafuri A; De Bernardo C; Palka G; Grammatico P
Haematologica; 2006 Aug; 91(8 Suppl):ECR33. PubMed ID: 16923517
[TBL] [Abstract][Full Text] [Related]
3. Early onset hereditary hemochromatosis resulting from a novel TFR2 gene nonsense mutation (R105X) in two siblings of north French descent.
Le Gac G; Mons F; Jacolot S; Scotet V; Férec C; Frébourg T
Br J Haematol; 2004 Jun; 125(5):674-8. PubMed ID: 15147384
[TBL] [Abstract][Full Text] [Related]
4. New TFR2 mutations in young Italian patients with hemochromatosis.
Biasiotto G; Camaschella C; Forni GL; Polotti A; Zecchina G; Arosio P
Haematologica; 2008 Feb; 93(2):309-10. PubMed ID: 18245657
[TBL] [Abstract][Full Text] [Related]
5. Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3.
Drake SF; Morgan EH; Herbison CE; Delima R; Graham RM; Chua AC; Leedman PJ; Fleming RE; Bacon BR; Olynyk JK; Trinder D
Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G323-8. PubMed ID: 16935854
[TBL] [Abstract][Full Text] [Related]
6. Two novel mutations, L490R and V561X, of the transferrin receptor 2 gene in Japanese patients with hemochromatosis.
Koyama C; Wakusawa S; Hayashi H; Suzuki R; Yano M; Yoshioka K; Kozuru M; Takayamam Y; Okada T; Mabuchi H
Haematologica; 2005 Mar; 90(3):302-7. PubMed ID: 15749661
[TBL] [Abstract][Full Text] [Related]
7. Analysis of HFE mutations and non-HFE gene mutations (TFR2 and SLC40A1) in patients with phenotypic hemochromatosis from the Basque Country.
Castiella A; Zapata E; De Juan MD; Zubiaurre L; Iribarren A; Otazua P; Fernandez J; Aragón L; Zuriarrain O; Gorostidi A
Int J Lab Hematol; 2016 Feb; 38(1):e5-7. PubMed ID: 26547814
[No Abstract] [Full Text] [Related]
8. Genetic and clinical heterogeneity of ferroportin disease.
Cremonesi L; Forni GL; Soriani N; Lamagna M; Fermo I; Daraio F; Galli A; Pietra D; Malcovati L; Ferrari M; Camaschella C; Cazzola M
Br J Haematol; 2005 Dec; 131(5):663-70. PubMed ID: 16351644
[TBL] [Abstract][Full Text] [Related]
9. [Practical use of genetic markers other than C282Y in iron overload disorders].
Brissot P
Gastroenterol Clin Biol; 2002 Nov; 26(11):991-3. PubMed ID: 12483130
[No Abstract] [Full Text] [Related]
10. Novel human pathological mutations. Gene symbol: SLC40A1. Disease: haemochromatosis, type 4.
Relvas L; Claro MT; Bento MC; Ribeiro ML
Hum Genet; 2009 Apr; 125(3):338. PubMed ID: 19309784
[No Abstract] [Full Text] [Related]
11. Genetic disorders of iron overload and the novel "ferroportin disease".
Cazzola M
Haematologica; 2003 Jul; 88(7):721-4. PubMed ID: 12857545
[No Abstract] [Full Text] [Related]
12. Type 3 hereditary hemochromatosis in a patient from sub-Saharan Africa: is there a link between African iron overload and TFR2 dysfunction?
Majore S; Ricerca BM; Radio FC; Binni F; Cosentino I; Gallusi G; De Bernardo C; Morrone A; Grammatico P
Blood Cells Mol Dis; 2013 Jan; 50(1):31-2. PubMed ID: 22981443
[No Abstract] [Full Text] [Related]
13. A novel ferroportin mutation in a Canadian family with autosomal dominant hemochromatosis.
Morris TJ; Litvinova MM; Ralston D; Mattman A; Holmes D; Lockitch G
Blood Cells Mol Dis; 2005; 35(3):309-14. PubMed ID: 16111902
[TBL] [Abstract][Full Text] [Related]
14. Variable age of onset and clinical severity in transferrin receptor 2 related haemochromatosis: novel observations.
Bardou-Jacquet E; Cunat S; Beaumont-Epinette MP; Kannengiesser C; Causse X; Sauvion S; Pouliquen B; Deugnier Y; David V; Loréal O; Aguilar-Martinez P; Brissot P; Jouanolle AM
Br J Haematol; 2013 Jul; 162(2):278-81. PubMed ID: 23600741
[No Abstract] [Full Text] [Related]
15. Hemochromatosis caused by mutations in the iron-regulatory proteins ferroportin and H ferritin.
Press RD
Mol Diagn; 2001 Dec; 6(4):347. PubMed ID: 11774199
[No Abstract] [Full Text] [Related]
16. Transferrin receptor 2 is frequently expressed in human cancer cell lines.
Calzolari A; Oliviero I; Deaglio S; Mariani G; Biffoni M; Sposi NM; Malavasi F; Peschle C; Testa U
Blood Cells Mol Dis; 2007; 39(1):82-91. PubMed ID: 17428703
[TBL] [Abstract][Full Text] [Related]
17. A rapid PCR-SSP assay for the hemochromatosis-associated Tyr250Stop mutation in the TFR2 gene.
Rivers CA; Barton JC; Acton RT
Genet Test; 2001; 5(2):131-4. PubMed ID: 11551099
[TBL] [Abstract][Full Text] [Related]
18. [Usefulness of a diagnostic algorithm hyperferritinemia: A case report of a Spanish family with hereditary hemochromatosis and mutation in SLC40A1 gene].
Vargas JA; Muñoz A; Samper B; Bornstein B
Med Clin (Barc); 2015 Jul; 145(1):42-3. PubMed ID: 25441019
[No Abstract] [Full Text] [Related]
19. Inactivation of the murine Transferrin Receptor 2 gene using the Cre recombinase: loxP system.
Wallace DF; Tonks ID; Zournazi A; Kay GF; Subramaniam VN
Genesis; 2004 May; 39(1):38-41. PubMed ID: 15124225
[TBL] [Abstract][Full Text] [Related]
20. A novel missense mutation c.470 A>C (p.D157A) in the SLC40A1 gene as a cause of ferroportin disease in a family with hyperferritinaemia.
Saja K; Bignell P; Robson K; Provan D
Br J Haematol; 2010 Jun; 149(6):914-6. PubMed ID: 20230395
[No Abstract] [Full Text] [Related]
[Next] [New Search]
